Multiphysics simulation of a compression–perfusion combined bioreactor to predict the mechanical microenvironment during bone metastatic breast cancer loading experiments

Metastatic Breast ◽

Multiphysics Simulation ◽

Mechanical Microenvironment

Multiphysics simulation of a compression - perfusion combined bioreactor to predict the mechanical microenvironment during bone metastatic breast cancer loading experiments

10.22541/au.159708642.22828855 ◽

2020 ◽

Author(s):

Boyuan Liu ◽

Suyue Han ◽

Yahya Modarres Sadeghi ◽

Maureen Lynch

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Multiphysics Simulation ◽

Mechanical Microenvironment

A review of the newer aromatase inhibitors in the management of metastatic breast cancer

Journal of Clinical Pharmacy and Therapeutics ◽

10.1046/j.1365-2710.1998.00145.x ◽

1998 ◽

Vol 23 (2) ◽

pp. 81-90 ◽

Cited By ~ 7

Author(s):

Reddy

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast

Influence of cumulative dose (CD) of trastuzumab administred wit taxanes vs pre-treatment CD of anthracyclin on left ventricular ejection fraction (LVEF) of metastatic breast cancer (MBC) patients

10.1016/s0959-8049(02)80427-0 ◽

2002 ◽

Vol 38 (11) ◽

pp. S131

Author(s):

B Aunoble

Keyword(s):

Breast Cancer ◽

Left Ventricular Ejection Fraction ◽

Ejection Fraction ◽

Cumulative Dose ◽

Metastatic Breast ◽

Left Ventricular ◽

Left Ventricular Ejection ◽

Ventricular Ejection Fraction ◽

Pre Treatment

Gemcitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Evaluation of response toxicity

10.1016/s0959-8049(02)80224-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S74 ◽

Cited By ~ 2

Author(s):

G Lerzo

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Previously Treated

Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer

10.1016/s0959-8049(02)80299-4 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

J Baselga

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Schedule ◽

Her2 Positive

Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer

10.1016/s0959-8049(02)80197-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S66-S67

Author(s):

B Ejlertsen

Keyword(s):

Breast Cancer ◽

Single Agent ◽

Metastatic Breast ◽

First Line ◽

Line Chemotherapy

Bevacizumab Approved for Metastatic Breast Cancer

Internal Medicine News ◽

10.1016/s1097-8690(08)70305-6 ◽

2008 ◽

Vol 41 (6) ◽

pp. 1-4

Author(s):

ELIZABETH MECHCATIE

Keyword(s):

Breast Cancer ◽

Metastatic Breast

Abstract #804323: Metastatic Breast Cancer Involving Thyoid Gland Presenting as a Stable 1 CM Nodule with High Risk Features on Ultrasonography

Endocrine Practice ◽

10.1016/s1530-891x(20)39577-x ◽

2020 ◽

Vol 26 ◽

pp. 267-268

Author(s):

Ahmad Al-Shoha

Keyword(s):

Breast Cancer ◽

High Risk ◽

Metastatic Breast

Abstract #42: Pan-hypopituitarism in a Patient with Metastatic Breast Cancer, and Review of Literature Regarding Pituitary Metastasis

Endocrine Practice ◽

10.1016/s1530-891x(20)46321-9 ◽

2004 ◽

Vol 10 ◽

pp. 16

Author(s):

Garumuni A. DeSilva ◽

Rennert ◽

Samuel Engel

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Review Of Literature ◽

Pituitary Metastasis

Abstract #144: Metastatic Breast Cancer: A Rare Cause of Adrenal Crisis

Endocrine Practice ◽

10.1016/s1530-891x(20)44318-6 ◽

2017 ◽

Vol 23 ◽

pp. 26

Author(s):

Samantha Tan ◽

Mohamad Rachid ◽

Irfan Siddiqui ◽

Tahira Yasmeen

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Adrenal Crisis